PeerVoice
PeerVoice Clinical Pharmacology Audio
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Clinical Pharmacology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts 13.12.2022 21:43
Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts
Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure 06.12.2022 27:18
Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes 05.12.2022 40:50
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs 05.12.2022 33:50
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch 05.12.2022 27:56
Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch
Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency 29.11.2022 51:49
Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency
Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression 24.11.2022 50:20
Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression
Luke Stephen Prockter Moore, FRCP, FRCPath, PhD - A Cohesive Multidisciplinary Approach to Antimicrobial Stewardship: Joining the Dots on Rapid Diagnostic Testing 24.11.2022 22:36
Luke Stephen Prockter Moore, FRCP, FRCPath, PhD - A Cohesive Multidisciplinary Approach to Antimicrobial Stewardship: Joining the Dots on Rapid Diagnostic Testing
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics 23.11.2022 32:45
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes? 17.11.2022 37:57
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered 14.11.2022 21:28
Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered
José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How 07.11.2022 23:06
José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice 03.10.2022 24:30
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC 29.09.2022 27:59
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit 29.09.2022 18:54
Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART? 20.09.2022 26:56
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care 07.09.2022 55:11
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions 07.09.2022 20:08
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
Question Time: Applying New Therapies for the Management of mTNBC 29.08.2022 38:18
Question Time: Applying New Therapies for the Management of mTNBC
New Biomarkers, New Targets in Advanced NSCLC 17.08.2022 20:20
New Biomarkers, New Targets in Advanced NSCLC
Managing Generalised Myasthenia Gravis: A Tale of Two Targets 10.08.2022 1:00:57
Managing Generalised Myasthenia Gravis: A Tale of Two Targets
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias 01.08.2022 18:31
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC 11.07.2022 37:39
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022 30.06.2022 19:16
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
How I Treat: Achieving Healing in CPF 07.06.2022 21:19
How I Treat: Achieving Healing in CPF
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.